Study of Soberana Plus vaccine candidate continues
Study of Soberana Plus vaccine candidate continues
20 de abril de 2021, 0:0Havana, Apr 20 (Prensa Latina) Studies of Cuba s Soberana Plus vaccine candidate continue in this capital in order to reinforce the protection and responsiveness of Covid-19 convalescing patients in the face of a possible reinfection. This is phase II A of clinical trials of this vaccine candidate from the Finlay Vaccines Institute (IFV), whose study is being carried out at the Hematology and Immunology Institute, in this capital.
The vaccination of a score of people of the 450 convalescing patients included in this phase of the study started on Saturday.
Cubaâs COVID-19 Vax Sought by CARICOM Countries, Venezuela to Make It
(AP Photo/John Locher, File)
Cuba is the only country in Latin America and the Caribbean developing COVID-19 vaccines. There has been an interest in these vaccines within the Member States of the Caribbean Community (CARICOM).
Now, Venezuelaâs President Nicolas Maduro says the country has signed a deal to produce two million doses per month of a Cuban coronavirus vaccine, adding that his government also managed to secure funds to fully pay for COVID jabs via COVAX, a global sharing mechanism.
âWeâve signed an agreement to produce in our laboratories⦠two million vaccines a month of the Abdala vaccine⦠for August, September, approximately,â Maduro said on Sunday in a television address, referring to one the four vaccines that are being developed by Cuba.
Havana, Apr 12 (Prensa Latina) A single dose of Cuba s vaccine candidate Soberana Plus can protect people against Covid-19 reinfection and improve their immune response to variants of the SARS-CoV-2 coronavirus, health authorities announced on Monday.
Cuba s work on Covid-19 vaccines underscored in Costa Rica
Cuba s work on Covid-19 vaccines underscored in Costa Rica
San Jose, Apr 6 (Prensa Latina) The former rector of the National University (UNA) of Costa Rica, Alberto Salom, on Tuesday highlighted Cuba s work on Covid-19 vaccines.
In a lengthy article published on La Republica newspaper, Salom pointed out that Cuba is a poor country that goes ahead in its experiments, in which a key role is played by the Finlay Vaccines Institute (IFV) and the Genetic Engineering and Biotechnology Center (CIGB), both in Havana.
The Finlay Institute was founded in 1991 and his strength lies in the production of vaccines of bacterial origin. It has been very successful in producing more than 12 vaccines, starting by the BC antimeningococcic vaccine.
Cuba climbs another step in search of its own Covid-19 vaccine plenglish.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from plenglish.com Daily Mail and Mail on Sunday newspapers.